14 July 2014 : Original article
The Pharmacokinetics of Everolimus in De Novo Kidney Transplant Patients Receiving Tacrolimus: An Analysis from the Randomized ASSET Study
Lionel RostaingABE, Maarten H.L. ChristiaansABE, John M. KovarikCE, Julio PascualABEDOI: 10.12659/AOT.890673
Ann Transplant 2014; 19:337-345
Related articles
12 Nov 2019 : Original article
Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients
Lin Yan, Zhi-Qiang Yang
DOI: 10.12659/AOT.918980
Ann Transplant 2019; 24:594-604
27 Aug 2019 : Original article
A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study
Jérôme Dumortier, Christophe Duvoux
DOI: 10.12659/AOT.916041
Ann Transplant 2019; 24:506-516
23 Oct 2018 : Original article
Everolimus Use for Intolerance or Failure of Baseline Immunosuppression in Adult Heart and Lung Transplantation
Shelby E. Kelsh, Reda Girgis
DOI: 10.12659/AOT.910952
Ann Transplant 2018; 23:744-750
05 Jan 2016 : Original article
Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization
Kyle M. Gardiner, Susan E. Tett
DOI: 10.12659/AOT.895664
Ann Transplant 2016; 21:1-11
07 Feb 2014 : Original article
Effect of different tacrolimus levels on early outcomes after kidney transplantation
Shehzad Rehman, Xuerong Wen
DOI: 10.12659/AOT.889858
Ann Transplant 2014; 19:68-75
12 May 2014 : Original article
Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats
Ivan Matia, Peter Fellmer
DOI: 10.12659/AOT.889870
Ann Transplant 2014; 19:225-232
17 Mar 2014 : Original article
An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients
Lars Bäckman, Carl-Axel Persson
DOI: 10.12659/AOT.890101
Ann Transplant 2014; 19:138-144
23 Jun 2014 : Original article
Incidence of malignant neoplasia after heart transplantation – a comparison between cyclosporine a and tacrolimus
Uwe Fuchs, Sarah Klein
DOI: 10.12659/AOT.890199
Ann Transplant 2014; 19:300-304
07 Jul 2014 : Original article
Early Conversion from Twice-Daily Tacrolimus to Once-Daily Extended Formulation in Renal Transplant Patients Before Hospital Discharge
Martin Jannot, Ingrid Masson
DOI: 10.12659/AOT.890262
Ann Transplant 2014; 19:320-324
20 Jun 2014 : Original article
Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation
Tomasz Urbanowicz, Hanna Baszyńska-Wachowiak
DOI: 10.12659/AOT.890268
Ann Transplant 2014; 19:295-299
20 Jun 2015 : Clinical Research
Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy
Jian-feng Zheng, Juan Lu
DOI: 10.12659/MSM.894669
Med Sci Monit 2015; 21:1781-1791
22 Mar 2016 : Original article
Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation
Gerold Thölking, Lea Siats
DOI: 10.12659/AOT.895898
Ann Transplant 2016; 21:167-179
26 May 2017 : Original article
Supplementary Administration of Everolimus Reduces Cardiac Systolic Function in Kidney Transplant Recipients
Kazuma Tsujimura, Morihito Ota
DOI: 10.12659/AOT.903414
Ann Transplant 2017; 22:315-322
26 Sep 2017 : Original article
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Fumiaki Kitazawa, Shin-ichi Fuchida
DOI: 10.12659/AOT.904505
Ann Transplant 2017; 22:575-580
28 Nov 2017 : Original article
Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience
Jinsoo Rhu, Kyo Won Lee
DOI: 10.12659/AOT.906041
Ann Transplant 2017; 22:707-718
18 Apr 2018 : Laboratory Research
Pharmacokinetic and Pharmacodynamics of Self-Assembled Cubic Liquid Crystalline Nanoparticle Gel After Transdermal Administration
Na Zhu, Xiao-xiang Wu
DOI: 10.12659/MSM.906140
Med Sci Monit 2018; 24: LBR2330-2338
08 May 2018 : Original article
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients
Jiang-Tao Tang, Lin Yan
DOI: 10.12659/AOT.907666
Ann Transplant 2018; 23:300-309
19 Dec 2017 : Case report
Transfer of Everolimus into Colostrum of a Kidney Transplant Mother
Bożena Kociszewska-Najman, Monika Szpotańska-Sikorska
DOI: 10.12659/AOT.907944
Ann Transplant 2017; 22:755-758
07 Aug 2013
Evolution to twice daily bolus intravenous tacrolimus: Optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant
Gregory I. Snell, Steven Ivulich
DOI: 10.12659/AOT.883993
Ann Transplant 2013; 18:399-407
29 Jul 2013
A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up
Bartosz Foroncewicz, Krzysztof Mucha
DOI: 10.12659/AOT.883986
Ann Transplant 2013; 18:384-392
19 Jul 2013
Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy
Jean-François Augusto, Jean-François Subra
DOI: 10.12659/AOT.883979
Ann Transplant 2013; 18:368-377
05 Feb 2013
Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation
Jun-Neng Roan, Chen-Hsi Chou
DOI: 10.12659/AOT.883812
Ann Transplant 2013; 18:43-52
31 Dec 2012
Early everolimus-induced pneumonitis in a renal transplant recipient: A case report
Katarzyna Sułkowska, Piotr Palczewski
DOI: 10.12659/AOT.883706
Ann Transplant 2012; 17(4): 144-148
31 Dec 2012
Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation
Frieder Keller, Susanne Wiesner
DOI: 10.12659/AOT.883694
Ann Transplant 2012; 17(4): 52-58
31 Dec 2012
Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: Results of a prospective randomized trial
Claudia Bösmüller, Robert Öllinger
DOI: 10.12659/AOT.883693
Ann Transplant 2012; 17(4): 45-51
26 Sep 2012
Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation
Maciej Bułanowski, Jerzy Chudek
DOI: 10.12659/AOT.883459
Ann Transplant 2012; 17(3): 61-68
29 Jun 2012
Tacrolimus-induced nephrotoxicity and genetic variability: A review
Violette M.G.J. Gijsen, Parvaz Madadi
DOI: 10.12659/AOT.883229
Ann Transplant 2012; 17(2): 111-121
31 Mar 2012
Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: A randomized, open-label multicenter study
Laetitia Albano, Eric Alamartine
DOI: 10.12659/AOT.882637
Ann Transplant 2012; 17(1): 58-67
23 Mar 2011
Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of Tacrolimus in Chinese renal transplant patients
Ping Wu, Xuefeng Ni
Ann Transplant 2011; 16(1): 54-60
30 Jun 2011
Effect of tacrolimus on energy metabolism in human umbilical endothelial cells
Sabine Illsinger, Catrin Göken
Ann Transplant 2011; 16(2): 68-75
30 Sep 2011
Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression
Amit Basu, John Falcone
Ann Transplant 2011; 16(3): 5-13
30 Sep 2011
Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation
Kyota Fukazawa, Seigo Nishida
Ann Transplant 2011; 16(3): 139-142
30 Dec 2011
Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients
Yuichi Muraki, Masanobu Usui
Ann Transplant 2011; 16(4): 55-62
30 Dec 2011
Pulmonary embolism and reactivation of tuberculosis during everolimus therapy in a kidney transplant recipient
Jolanta Barbara Fijałkowska-Morawska, Marta Jagodzińska
Ann Transplant 2011; 16(4): 107-110
28 Sep 2010
Effect of tacrolimus dosing on glucose metabolism in an experimental rat model
Maciej Malinowski, Johann Pratschke
Ann Transplant 2010; 15(3): 60-65
01 Jan 2010
Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient
Mehat Abdel Halim, Torki Al-Otaibi
Ann Transplant 2010; 15(1): 57-60
01 Jan 2009
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients
Alessio Provenzani, Monica Notarbartolo
Ann Transplant 2009; 14(1): 23-31
21 Feb 2009
Cyclosporine A, but not tacrolimus, is associated with impaired proliferation and differentiation of human osteoblast-like cells in vitro
Rodrigo Oliveira Moreira, Leandro Souza Thiago
Med Sci Monit 2009; 15(3): BR65-70
17 Jun 2008
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients
Hakeam A. Hakeam, Ahmed H. Al-Jedai
Ann Transplant 2008; 13(2): 46-53
29 Apr 2008
The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients
Silvia Tirelli, Mariano Ferraresso
Med Sci Monit 2008; 14(5): CR251-254
28 Dec 2007
Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation
Susumu Eguchi, MItsuhisa Takatsuki
Ann Transplant 2007; 12(4): 11-15
30 Jan 2007
Nontoxic effect of tacrolimus on normally perfused isolated liver and protective effect on hypoperfused liver
Richard Nakache, Ivgeny Isretil
Med Sci Monit 2007; 13(2): BR32-39
16 Jun 2006
Conversion From Cyclosporine-Based Immunosuppression to Tacrolimus/ Mycophenolate Mofetil in Patients with Refractory and Ongoing Acute Renal Allograft Rejection
Maria Boratynska, Miroslaw Banasik
Ann Transplant 2006; 11(2): 51-56
01 Jan 1970
Conversion from Cyclosporine to Tacrolimus improves Renal Function and Lipid Profile after Cardiac Transplantation
Miroslaw Garlicki, Pawel Czub
Ann Transplant 2006; 11(1): 24-27
06 Dec 2003
Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
Z Włodarczyk, J J Wałaszewski
Ann Transplant 2002; 7(3): 28-31
08 Jun 2001
The Effect of Bone Marrow Transplantation on Survival of Allogeneic Pancreatic Islets with Short-Term Tacrolimus Conditioning in Rats
P Girman, J Kriz
Ann Transplant 2001; 6(2): 43-45
Most Viewed Current Articles
15 Aug 2023 : Review article 7,203
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
03 Jan 2023 : Original article 7,086
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
16 May 2023 : Original article 6,914
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
28 May 2024 : Original article 6,394
Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...DOI :10.12659/AOT.943281
Ann Transplant 2024; 29:e943281